Abstract
Background High body mass index (BMI) is an important contributor to higher blood pressure (BP) levels and its deleterious consequences. However, the strength of this association may be context-specific and differ across time due to increases in medication use or secular changes in body composition. Thus, we utilised two independent data sources to investigate if associations between BMI and systolic BP (SBP) in Britain changed from 1989-2018.
Methods We used 23 repeated cross-sectional datasets—the Health Survey for England (HSE) at ≥25 years (1994–2018; N=126,742); and three British birth cohorts (born 1946, 1958, and 1970) with outcomes available at 43-46 years (N=18,657). Anthropometry and BP were measured using standard protocols. We used linear and quantile regression to investigate cross-sectional associations between BMI and SBP.
Results In HSE, associations were weaker in subsequent years, and this trend was most pronounced amongst older adults—after accounting for sex, treatment and education, the mean difference in SBP per 1 kg/m2 increase in BMI amongst adults ≥55 years was 0.75mmHg (95% CI: 0.60, 0.90) in 1994, 0.66mmHg (0.46, 0.85) in 2003, and 0.53mmHg (0.35, 0.71) in 2018. In cohorts, BMI and SBP associations were of similar magnitude in 1958 and 1970 cohorts and weaker in the 1946 cohort. Quantile regression analyses suggested that associations between BMI and SBP were present both below and above the hypertension threshold.
Conclusion The consequences of BMI may differ across time and by age —associations between BMI and SBP appear to have weakened in recent decades, particularly in older ages. Thus, at older ages, this weakening strength of association may partly offset the public health impacts of increases in obesity prevalence. However, BMI remains positively associated with SBP in all adult age groups, highlighting the potential adverse consequences of the ongoing obesity epidemic.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
DB is supported by the Economic and Social Research Council (grant number ES/M001660/1), The Academy of Medical Sciences / Wellcome Trust (HOP001/1025), and Medical Research Council (MR/V002147/1). The HSE is funded by NHS Digital; SS is funded to conduct the annual HSE. RH is Director of CLOSER which is funded by the Economic and Social Research Council (award reference: ES/K000357/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Multiple data sets are used; each study and data collection used has obtained ethical approval for data collection and subsequent analysis (1958 cohort: South East MREC (ref. 01/1/44); 1970 cohort: National Research Ethics Service (NRES) Committee South East Coast - Brighton and Sussex (Ref. 15/LO/1446); HSE: East Midlands - Nottingham 2 Research Ethics Committee (ref: 15/EM/0254).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data are available upon request at the links provided
